EQNX logo

EQUINOX NEPREMICNINE d.d LJSE:EQNX Stock Report

Last Price

€58.50

Market Cap

€104.6m

7D

0%

1Y

17.0%

Updated

21 Nov, 2024

Data

Company Financials

EQUINOX NEPREMICNINE d.d.

LJSE:EQNX Stock Report

Market Cap: €104.6m

EQNX Stock Overview

Engages in the rental and operation of real estate properties in Slovenia. More details

EQNX fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance3/6
Financial Health4/6
Dividends1/6

EQUINOX NEPREMICNINE d.d. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for EQUINOX NEPREMICNINE d.d
Historical stock prices
Current Share Price€58.50
52 Week High€59.00
52 Week Low€48.80
Beta-0.070
11 Month Change0.86%
3 Month Change2.63%
1 Year Change17.00%
33 Year Changen/a
5 Year Changen/a
Change since IPO58.11%

Recent News & Updates

Recent updates

Shareholder Returns

EQNXSI Real EstateSI Market
7D0%-1.4%0.1%
1Y17.0%6.5%35.7%

Return vs Industry: EQNX exceeded the SI Real Estate industry which returned 6.5% over the past year.

Return vs Market: EQNX underperformed the SI Market which returned 35.7% over the past year.

Price Volatility

Is EQNX's price volatile compared to industry and market?
EQNX volatility
EQNX Average Weekly Movement3.6%
Real Estate Industry Average Movement3.8%
Market Average Movement2.4%
10% most volatile stocks in SI Market3.5%
10% least volatile stocks in SI Market1.7%

Stable Share Price: EQNX's share price has been volatile over the past 3 months compared to the SI market.

Volatility Over Time: EQNX's weekly volatility (4%) has been stable over the past year, but is still higher than 75% of SI stocks.

About the Company

FoundedEmployeesCEOWebsite
2021n/an/aequinox.si

EQUINOX NEPREMICNINE d.d. engages in the rental and operation of real estate properties in Slovenia. Its properties include hotels, offices, and apartments. The company was founded in 2021 and is headquartered in Ljubljana, Slovenia.

EQUINOX NEPREMICNINE d.d. Fundamentals Summary

How do EQUINOX NEPREMICNINE d.d's earnings and revenue compare to its market cap?
EQNX fundamental statistics
Market cap€104.65m
Earnings (TTM)€1.28m
Revenue (TTM)€8.50m

82.0x

P/E Ratio

12.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EQNX income statement (TTM)
Revenue€8.50m
Cost of Revenue€2.03m
Gross Profit€6.46m
Other Expenses€5.19m
Earnings€1.28m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.71
Gross Margin76.08%
Net Profit Margin15.03%
Debt/Equity Ratio21.2%

How did EQNX perform over the long term?

See historical performance and comparison

Dividends

2.9%

Current Dividend Yield

221%

Payout Ratio